The race to commercialize cell therapies is forcing bioprocessing innovators to confront one of the field’s most persistent manufacturing bottlenecks: isolating fragile hematopoietic stem cells (HSCs) ...

Researchers have unveiled a microfluidic device that significantly improves the separation of tumor cells and clusters from malignant effusions. This novel technology promises to advance the diagnosis ...